دورية أكاديمية

Late recurrence of cervical cancer, retrospective study from a single cancer institute.

التفاصيل البيبلوغرافية
العنوان: Late recurrence of cervical cancer, retrospective study from a single cancer institute.
المؤلفون: Elmaghraby, Nermine, Nirmalanantham, P., Sur, M., Schnarr, K., Elit, L., Aziz, T., Kazerouni, H., Wright, J., Lytwyn, A.
المصدر: Canadian Journal of Pathology; 2018 Supplement, Vol. 10, p36-36, 1/3p
مصطلحات موضوعية: CERVICAL cancer diagnosis, CANCER in women, CANCER relapse, CLINICAL pathology, IMMUNOHISTOCHEMISTRY
مستخلص: Background: Women with cervical cancer have 8-25% recurrence risk, and 89%-99% recurrences present within 5 years of the primary cancer. Literature is limited on late recurrences 5 years after the primary cancer. Objectives: Describe clinical, radiologic, pathologic characteristics of late recurrent cervical cancer. Methodology: This is a retrospective study at a single cancer institute. The computerized pathology database was searched from years 1995 to 2011, cases then handsearched for late recurrences. Clinical, radiology and pathology reports were reviewed. Results: We identified 32 patients with recurrent cervical cancer; of these 7 presented 7-36 years after treatment. Four were squamous (SCC) and 3 adenocarcinomas. Six were stage IB or higher; one was IA with lymphovascular invasion. Recurrences occurred in vaginal vault, vesicovaginal fistula, bladder neck, cervix, femur, ovary, iliac and para-aortic lymph nodes. Ancillary testing to exclude a second primary and confirm cervical origin was used in 3 patients whose primary cervical cancers had occurred 8,13, and 19 years earlier: oncogenic human papillomavirus tissue testing was positive in 2 cases, and in the third case p16 was positive together with negative immunohistochemistry specific for other sites. Conclusion: Late cervical cancer recurrence is uncommon and a second primary may need to be considered. Pathology work up will depend on the clinical, imaging and morphological context. Testing for p16 and HPV may be useful. [ABSTRACT FROM AUTHOR]
Copyright of Canadian Journal of Pathology is the property of Canadian Association of Pathologists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index